ADOCIA Revenue and Competitors
Estimated Revenue & Valuation
- ADOCIA's estimated annual revenue is currently $17.4M per year.
- ADOCIA's estimated revenue per employee is $155,000
Employee Data
- ADOCIA has 112 Employees.
- ADOCIA grew their employee count by -13% last year.
ADOCIA's People
| Name | Title | Email/Phone |
|---|
ADOCIA Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is ADOCIA?
"Innovative medicine for everyone, everywhere" Listed on the Euronext stock market, Adocia is a clinical-stage biotech company specialized in the development of best-in-class medicine relying on innovative formulations of already-approved therapeutic proteins. Adocia operates in the diabetes and metabolic disease field. The proprietary BioChaperone® technological platform is designed to enhance the effectiveness and safety of therapeutic proteins and their ease of use for patients. For more information, visit our website: www.adocia.com For careers offers, please click to the following link : http://offres.adocia.com/en
keywords:N/A
N/A
Total Funding
112
Number of Employees
$17.4M
Revenue (est)
-13%
Employee Growth %
N/A
Valuation
N/A
Accelerator
ADOCIA News
Adocia (Euronext Paris: FR0011184241 ADOC) (Paris:ADOC), a clinical-stage biopharmaceutical company focused on the research and...
Adocia: Number of Shares and Voting Rights of ADOCIA as of March 31st, 2022. April 15, 2022 12:00 PM Eastern Daylight Time. LYON, France--(BUSINESS...
LYON, France, March 28, 2022 (GLOBE NEWSWIRE) -- Adocia (Euronext Paris : FR0011184241 ADOC), a clinical-stage biopharmaceutical company...
Other Companies in LYON
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | N/A | 118 | 30% | N/A |
#2 | $21.4M | 119 | 3% | N/A |
#3 | $38.8M | 120 | 2% | N/A |
#4 | $14.4M | 120 | 52% | N/A |
#5 | $26.8M | 122 | 8% | N/A |